Eurofins-Cerep
ISIN: FR0013256518 | Ticker: ALECR
Eurofins Scientific through its subsidiaries is the world leader in food, environment, pharmaceutical and cosmetic product testing, discovery pharmacology, forensics, advanced material sciences, and in agroscience Contract Research services. It is also one of the global independent market leaders in genomics and in the support of clinical studies, as well as in BioPharma Contract Development and Manufacturing. In addition, Eurofins is one of the key emerging players in specialty esoteric and molecular clinical diagnostic testing in Europe and the USA.
With 58,000 staff across a network of more than 1,000 independent companies in 54 countries and operating 900 laboratories, Eurofins offers a portfolio of over 200,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products, as well as for innovative clinical diagnostics.
1989
Served areaWorldwide
Headcount58,000
HeadquartersLe Bois l'Evêque, 86600 Celle-Lévescault – France
5,044
IPOJan. 1, 2020
Stock exchange(s)Euronext Paris